Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARISE: Succinobucol in CAD
NCT00066898Phase 3Unknown
- Sponsor
- AtheroGenics, Inc.
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of succinobucol in coronary artery disease (CAD), sponsored by AtheroGenics, Inc.. Status: unknown.
02
Drugs
succinobucol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00066898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066898.